Halaman 2 - Kemoterapi untuk kanker hati Dokter Terbaik - TOP-36 dokter

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Bernd Hertenstein memiliki 32 tahun keahlian di bidang onkologi, berspesialisasi dalam teknik kemoterapi canggih untuk kanker hati di Klinik Bremen-Mitte.

• Terampil dalam ablasi frekuensi radio hati
• Ahli dalam kemoembolisasi hati
• Melakukan transplantasi sel punca dan sumsum tulang
• Berkontribusi pada banyak publikasi onkologi

Dr. Raj telah melakukan 50.000+ operasi kanker dan berpartisipasi dalam 200+ uji klinis, membawa keahlian luas dalam kemoterapi kanker hati di HCG Manavata Cancer Centre.

• 19 tahun pengalaman dalam onkologi bedah
• Terlatih di Tata Memorial Hospital dan Royal College of Surgeons, Edinburgh
• Spesialisasi dalam onkologi bedah payudara dan toraks
• Profesor untuk DNB Superspecialty Surgical Oncology dan Bedah Payudara

Mempresentasikan penelitian tentang kanker lambung di Gastrointestinal Cancer Symposium yang elit oleh ASCO. Dr. Valame berspesialisasi dalam terapi target dengan fokus pada dasar molekuler kanker.

• Menyelesaikan DNB dalam Onkologi Medis dari Indraprastha Apollo Hospital
• Registrar dalam Onkologi Medis di Jawaharlal Nehru Cancer Hospital
• Memberikan kuliah di International Winter School of Oncology
• MD dalam Penyakit Dalam dari Shyam Shah Medical College

Dr. Lalit Banswal telah melakukan lebih dari 10.000 operasi besar, dengan fokus pada bedah kanker invasif minimal di HCG Manavata Cancer Centre.

• Spesialisasi dalam bedah kanker gastrointestinal
• Pelatihan Fellowship di Tata Medical Center, Kolkata
• Menerbitkan berbagai makalah penelitian nasional dan internasional
• Mantan Asisten Profesor di State Cancer Institute dan Government Cancer Hospital, Aurangabad

Dr. Ahmer Arif Shaikh berspesialisasi dalam kanker mulut dan pelestarian organ, dengan pelatihan fellowship dalam Onkologi Bedah Kepala & Leher.

• 3 tahun pengalaman dalam Onkologi Bedah
• Mahir dalam operasi maksilofasial mayor dan kepala & leher
• Peneliti dengan banyak publikasi
• Bekerja di HCG Manavata Cancer Centre - Nasik

Dr. Shruti Kate berspesialisasi dalam kemoterapi untuk kanker hati, dengan keahlian dalam perawatan lanjutan seperti imunoterapi dan terapi metronomik. Beliau menempuh pendidikan di Tata Memorial Hospital – pusat kanker terkemuka di India.

• Berpengalaman dalam mengobati tumor padat, termasuk kanker hati
• Anggota ASCO, ESMO, dan perkumpulan onkologi bergengsi lainnya
• Mempresentasikan penelitian kanker paru-paru di Konferensi Dunia tentang Kanker Paru-paru
• Menggunakan teknik terbaru seperti imunoterapi untuk kanker stadium lanjut

Menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid – Dr. Borde membawa keahlian kedokteran nuklir yang luas untuk perawatan kanker hati.

• 12 tahun pengalaman dalam kedokteran nuklir
• Mahir dalam terapi radioiodine & Lu-177 RN
• Makalah yang diterbitkan di berbagai jurnal medis
• Bekerja di HCG Manavata Cancer Centre

Dr. Sridhar P.S. berspesialisasi dalam radioterapi dengan pendidikan luas dan keanggotaan di berbagai perkumpulan onkologi utama.

• Berpengalaman dalam mengobati kanker hati dengan radioterapi
• Anggota Association of Radiation Oncology of India
• Bagian dari Society for Neuro-Oncology dan Bangalore Oncology Group
• Diplomate of National Board dalam radioterapi